113 related articles for article (PubMed ID: 17532962)
1. Antiplatelet therapy in patients receiving aortic bioprostheses: a report of clinical and instrumental safety.
di Marco F; Grendene S; Feltrin G; Meneghetti D; Gerosa G
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1597-603. PubMed ID: 17532962
[TBL] [Abstract][Full Text] [Related]
2. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
[TBL] [Abstract][Full Text] [Related]
3. Solid and gaseous cerebral microembolization after biologic and mechanical aortic valve replacement: investigation with multirange and multifrequency transcranial Doppler ultrasound.
Guerrieri Wolf L; Choudhary BP; Abu-Omar Y; Taggart DP
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):512-20. PubMed ID: 18329462
[TBL] [Abstract][Full Text] [Related]
4. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
7. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
[TBL] [Abstract][Full Text] [Related]
8. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
[TBL] [Abstract][Full Text] [Related]
9. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
[TBL] [Abstract][Full Text] [Related]
10. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation is unnecessary after biological aortic valve replacement.
Moinuddeen K; Quin J; Shaw R; Dewar M; Tellides G; Kopf G; Elefteriades J
Circulation; 1998 Nov; 98(19 Suppl):II95-8; discussion II98-9. PubMed ID: 9852888
[TBL] [Abstract][Full Text] [Related]
12. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial.
Puskas J; Gerdisch M; Nichols D; Quinn R; Anderson C; Rhenman B; Fermin L; McGrath M; Kong B; Hughes C; Sethi G; Wait M; Martin T; Graeve A;
J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1202-1210; discussion 1210-1. PubMed ID: 24512654
[TBL] [Abstract][Full Text] [Related]
13. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
14. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
15. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
Colli A; Mestres CA; Castella M; Gherli T
J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement.
Mathew JG; Spyropoulos AC; Yusuf A; Vincent J; Eikelboom J; Shestakovska O; Fremes S; Noora J; Guo L; Peterson M; Pai M; Whitlock R
Thromb Haemost; 2014 Dec; 112(6):1120-8. PubMed ID: 25183209
[TBL] [Abstract][Full Text] [Related]
17. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
[TBL] [Abstract][Full Text] [Related]
18. Early postoperative anticoagulation after mechanical valve replacement: a Canadian survey.
Kulik A; Rubens FD; Baird D; Wells PS; Kearon C; Mesana TG; Lam BK
J Heart Valve Dis; 2006 Jul; 15(4):581-7. PubMed ID: 16901058
[TBL] [Abstract][Full Text] [Related]
19. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses.
Brown ML; Schaff HV; Lahr BD; Mullany CJ; Sundt TM; Dearani JA; McGregor CG; Orszulak TA
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):878-84; discussion 884. PubMed ID: 18374773
[TBL] [Abstract][Full Text] [Related]
20. Mid term outcome and quality of life after aortic valve replacement in elderly people: mechanical versus stentless biological valves.
Florath I; Albert A; Rosendahl U; Alexander T; Ennker IC; Ennker J
Heart; 2005 Aug; 91(8):1023-9. PubMed ID: 16020589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
